1 Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.

2 Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines.

3 editorial: murine models of leukemia and lymphoma

4 bet inhibitors in the treatment of hematologic malignancies: current insights and future prospects

5 advances in chromatin remodeling and its role in the molecular mechanism of leukemia

6 a novel quantitative fluorescent reporter assay for rag targets and rag activity

7 c/ebp-induced transdifferentiation reveals granulocyte-macrophage precursor-like plasticity of b cells

8 untargeted metabolomics identifies key metabolic pathways altered by thymoquinone in leukemic cancer cells

9 adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a brazilian hospital

10 primary intracranial granulocytic sarcoma: a case report and review of literature

11 next generation sequencing: advances in characterizing the methylome

12 gingival inflammation and platelet count in patients with leukemia: preliminary results

13 therapeutic options for patients who are not eligible for intensive chemotherapy

14 high throughput fish analysis: a new, sensitive option for evaluation of hematological malignancies

15 cases series of malignant lymphohematopoietic disorder in korean semiconductor industry

16 importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance

17 the promyelocytic leukemia zinc finger protein (plzf): two decades of molecular oncology

18 occurrence of infections and its relationship to hemogram in patients with acute leukaemia.

19 lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia

20 transformation of canine lymphoma/leukemia to more aggressive diseases: anecdotes or reality?

21 mechanism of generation of therapy related leukemia in response to anti-topoisomerase ii agents

22 myeloid derived suppressor cells as therapeutic target in hematological malignancies

23 the role of micro-ribonucleic acids in normal hematopoiesis and leukemic t-lymphogenesis

24 new trends in cancer therapy: targeting ion channels and transporters

25 mediastinal nonleukemic granulocytic sarcoma with cardiac infiltration sarcoma granulocítico mediastinal não associado à leucemia com infiltração cardíaca

26 in silico evidence of signaling pathways of notch mediated networks in leukemia

27 cellular and molecular targets of resveratrol on lymphoma and leukemia cells

28 extracellular vesicles in hematological disorders

29 bcl-2 and bax interaction in b-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia

30 presença de anticorpo anti-lutheran b em paciente com leucemia linfóide aguda anti-lutheran b in a patient with acute lymphoblastic leukemia

31 targeting cell cycle regulators in hematologic malignancies

32 bioinformatic description of immunotherapy targets for pediatric t-cell leukemia and the impact of normal gene sets used for comparison

33 what we are learning on htlv-1 pathogenesisfrom animal models

34 therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated human diseases

35 Antimicrobial and antileukemic effects: in vitro activity of aqueous leaf extract.

36 Induction of Lymphosarcoma in Sheep by Bovine Leukemia Virus23

37 Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

38 Apoptosis and content of mobile lipid domains in human leukemia K-562 cells induced to differentiate by quercetin or dimethyl sulfoxide.

39 Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia

40 Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia

41 Targeting CD20 in chronic lymphocytic leukemia

42 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

43 Targeting CD20 in chronic lymphocytic leukemia

44 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

45 Targeting CD20 in chronic lymphocytic leukemia

46 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

47 Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations

48 Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy

49 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

50 The aberrant epigenetic regulation and epigenomic landscape alteration in human acute myelogenous leukemia and the emerged agents that target epigenetic regulators

51 [Precision medicine for acute myeloid leukemia based on genomic profiling].

52 A point mutation to the long terminal repeat of bovine leukemia virus related to viral productivity and transmissibility.

53 Childhood leukemia and traffic air pollution in Taiwan: petrol station density as an indicator.

54 Association of childhood leukemia with residential exposure to petrochemical air pollution in taiwan.

55 Caregiver Burden in the Patients of Acute Myeloblastic Leukemia.

56 New drugs approved for acute myeloid leukemia (AML) in 2018.

57 20-Cyclopropyl-cholecalciferol vitamin D<inf>3</inf>analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines

58 Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.

59 Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

60 Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.

61 Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

62 Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.

63 Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China

64 Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.

65 Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

66 The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.

67 Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

68 Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

69 T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.

70 Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).

71 Migratory polyarthritis as a paraneoplastic syndrome in childhood leukemia.

72 A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia.

73 Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

74 [Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].

75 Prophylactic Measures During Induction for Acute Myeloid Leukemia.

76 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

77 Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

78 Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

79 Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

80 Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis of 17 Case-Control Studies.

81 Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia the Activation of Notch Signaling Pathway.

82 In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.

83 Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

84 Benzene and leukemia: from scientific evidence to regulations. A historical example

85 The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.

86 In vitro activity of resorcinarene–chlorambucil conjugates for therapy in human chronic myelogenous leukemia cells

87 The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.

88 Extremely Low Frequency Electromagnetic Field (ELF-EMF) and childhood leukemia near transmission lines: a review

89 Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

90 Assessment of response to imatinib therapy in patients with chronic myeloid leukemia with e13a2 and e14a2 transcripts of BCR/ABL1 gene.

91 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

92 Vitamin B6 Addiction in Acute Myeloid Leukemia.

93 Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.

94 Phenotypic characterization of macrophages in the BMB sample of human acute leukemia.

95 Targeted removal of leukemia cells from the circulating system by whole-body magnetic hyperthermia in mice.

96 Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5351), 10.1038/s41467-019-13259-2)

97 [The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].

98 Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.

99 Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia

100 Prevalence and molecular epidemiology of bovine leukemia virus in Colombian cattle

101 The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

Keyword Connections

Journals

Research Groups

Bibliographies